Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
Summary
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the 10 best biotech stocks with highest upside potential. On April 16, Morgan Stanley increased the price...
Description
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the 10 best biotech stocks with highest upside potential. On April 16, Morgan Stanley increased the price...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source